What is the recommended treatment for strep throat?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Strep Throat Treatment

Penicillin V (250 mg twice or three times daily for 10 days) or amoxicillin (50 mg/kg once daily, maximum 1000 mg, for 10 days) remains the first-line treatment for Group A streptococcal pharyngitis due to proven efficacy, safety, narrow spectrum, and low cost. 1, 2

First-Line Treatment Options

Penicillin-Based Therapy

  • Oral penicillin V: Children receive 250 mg twice or three times daily; adolescents and adults receive 250 mg three to four times daily or 500 mg twice daily for 10 days 1
  • Amoxicillin: 50 mg/kg once daily (maximum 1000 mg) for 10 days is equally effective and offers improved adherence due to convenient once-daily dosing 1, 2, 3
  • Intramuscular benzathine penicillin G: Single dose of 600,000 units for patients <27 kg or 1,200,000 units for patients ≥27 kg—preferred when oral compliance is unlikely 1, 2

Why Penicillin Remains First-Line

  • Group A streptococci have shown no resistance to penicillin over five decades 1
  • Narrow antimicrobial spectrum minimizes disruption of normal flora 1
  • Modest cost compared to alternatives 1
  • The 10-day duration is necessary to achieve maximal pharyngeal eradication and prevent acute rheumatic fever 1, 3

Treatment for Penicillin-Allergic Patients

Non-Anaphylactic Penicillin Allergy

  • First-generation cephalosporins are first-line alternatives 1, 2, 4:
    • Cephalexin: 20 mg/kg per dose twice daily (maximum 500 mg per dose) for 10 days 1, 4
    • Cefadroxil: 30 mg/kg once daily (maximum 1 g) for 10 days 1, 4
  • These should NOT be used in patients with immediate/anaphylactic hypersensitivity to β-lactams due to 10% cross-reactivity risk 1, 2, 4

Immediate/Anaphylactic Penicillin Allergy

  • Clindamycin: 7 mg/kg per dose three times daily (maximum 300 mg per dose) for 10 days—demonstrates high efficacy even in chronic carriers with only 1% resistance in the United States 1, 2, 4, 5
  • Azithromycin: 12 mg/kg once daily (maximum 500 mg) for 5 days—the only macrolide requiring just 5 days due to prolonged tissue half-life 1, 2, 4, 6
  • Clarithromycin: 7.5 mg/kg per dose twice daily (maximum 250 mg per dose) for 10 days 1, 2, 4

Important Caveats for Macrolides

  • Macrolide resistance among Group A streptococci is approximately 5-8% in the United States but varies geographically 2, 4
  • Check local resistance patterns before prescribing macrolides 4
  • Erythromycin (20-40 mg/kg/day divided 2-3 times daily for 10 days) has high gastrointestinal side effects and is less preferred than newer macrolides 1, 7

Treatment Duration and Efficacy

Why 10 Days Matters

  • A full 10-day course is required for most antibiotics to achieve maximal pharyngeal eradication of Group A streptococci 1, 2
  • The 10-day duration specifically prevents acute rheumatic fever 1, 3
  • Shorter courses (3-7 days) of penicillin show inferior outcomes compared to 10 days 1
  • Exception: Azithromycin requires only 5 days due to unique pharmacokinetics 1, 2, 4, 6

Evidence on Cephalosporins vs. Penicillin

  • Meta-analyses show cephalosporins have slightly higher bacteriologic cure rates than penicillin (OR 2.29-2.34), but clinical differences are small and not clinically relevant 1
  • Five-day courses of certain cephalosporins may be as effective as 10-day penicillin, but this cannot be definitively recommended yet 1, 8

Adjunctive Therapy

  • Analgesics/antipyretics: Acetaminophen or NSAIDs for moderate to severe symptoms or high fever 1, 2
  • Avoid aspirin in children due to Reye syndrome risk 1, 2, 4
  • Corticosteroids are NOT recommended as adjunctive therapy 1, 2, 4

Follow-Up and Testing

When NOT to Test

  • Routine post-treatment throat cultures or rapid antigen tests are NOT recommended for asymptomatic patients who completed therapy 1, 2, 5
  • Routine testing of asymptomatic household contacts is NOT recommended 1

When to Consider Testing

  • Patients with recurrent pharyngitis and positive cultures may be chronic carriers experiencing viral infections—antibiotics generally not needed unless specific circumstances exist (community outbreak, family history of rheumatic fever, excessive anxiety) 1
  • Follow-up testing may be considered for patients with history of rheumatic fever 4

Recurrent Strep Throat

  • If recurrence occurs shortly after completing therapy, retreat with the same antibiotic or switch to intramuscular benzathine penicillin G if oral compliance is questionable 1
  • For multiple recurrences, alternative regimens such as clindamycin, amoxicillin-clavulanate, or benzathine penicillin G with rifampin may be more effective 2
  • Clindamycin is particularly effective for chronic carriers due to high eradication rates 2, 4, 5

Common Pitfalls to Avoid

  • Do not use trimethoprim-sulfamethoxazole for strep throat—high resistance rates (50%) make it ineffective 4
  • Do not prescribe shorter courses than recommended (except azithromycin)—leads to treatment failure and complications 4
  • Do not assume all penicillin-allergic patients cannot receive cephalosporins—only those with immediate/anaphylactic reactions should avoid them 4
  • Do not perform routine post-treatment cultures on asymptomatic patients—this is not recommended and leads to unnecessary treatment 1, 2, 5
  • Patients are non-contagious after 24 hours of appropriate antibiotic therapy 2, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Strep Throat Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Streptococcal Infections in Patients with Penicillin Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Clindamycin Treatment for Streptococcal Pharyngitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Macrolides in the management of streptococcal pharyngitis/tonsillitis.

The Pediatric infectious disease journal, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.